Avicanna Inc's stock has seen a notable uptick of 4.17% in the last trading session, reflecting growing investor confidence.
In the latest trading session, Avicanna Inc (AVCN.TO) experienced a significant rise of 4.17%, closing at CA$0.13. This upward movement suggests a positive sentiment among investors, despite the absence of recent news that could have directly influenced the stock's performance.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Avicanna Inc
AVCN.TO
AVCN.TO
Avicanna Inc
WealthAwesomeMarket cap
$15.72M
52W high
$0.30
52W low
$0.10
1W change
-7.41%
Beta
0.33
Analyst Price Targets
Based on analyst covering AVCN
Wall Street analysts forecast AVCN stock price to rise 460.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.70
+460.0% Upside
Current Price
C$0.13
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AVCN's historical volatility
30-Day Vol
70.3%
Annualized
90-Day Vol
65.4%
Annualized
Trend (90d)
-47.6%
Annualized drift
90d Mean
C$0.11
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.12 | C$0.09 – C$0.15 |
| 60 trading days | C$0.11 | C$0.08 – C$0.16 |
| 90 trading days | C$0.11 | C$0.07 – C$0.16 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: The recent gain in Avicanna's stock price may indicate a rebound in investor confidence, potentially driven by the company's strategic positioning in the cannabinoid market and its ongoing efforts to expand its product offerings.
4.17% Increase in Stock Price
Avicanna's stock has risen by 4.17% in the last trading session, reflecting a market cap of approximately CA$14.47 million.
Bull case
Investors might be feeling optimistic about Avicanna's future, especially after recent strategic investments and the successful launch of new platforms like MyMedi.ca. These developments could boost revenue and strengthen the company’s presence in the market.
Bear case
However, despite the positive movement, Avicanna's financials still show some challenges. The company has a negative profit margin and doesn’t pay dividends, which might raise concerns for more cautious investors.
Advertisement
Investor Sentiment and Market Performance
The recent rise in Avicanna's stock price can be attributed to a shift in investor sentiment, likely influenced by the company's strategic initiatives and market positioning. As the cannabinoid sector continues to evolve, companies like Avicanna are increasingly seen as potential leaders, attracting investor interest.
Company Developments and Future Outlook
While there were no recent announcements directly impacting the stock, Avicanna's previous initiatives, such as the launch of MyMedi.ca, demonstrate its commitment to growth in the cannabinoid market. Investors may be looking forward to future developments that could further solidify the company's position.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
